IL4R and viral infectious disease: Once we performed our subgroup analyses, we found that selective JAKis were associated with increased risk of viral infections (OR: 2.60 [1.26–5.36]) as well as IL-4R targeted biologics (OR: 1.97 [1.07–3.61]) (Table 4).